In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and Ceci Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Ruxolitinib cream showed positive results in children 2- to 11-years-old with mild to moderate atopic dermatitis (AD), according to data of a poster presented at the American Academy of Dermatology Annual Meeting in San Diego from March 8 to 12.
The study suggests financial barriers are negatively impacting the wellbeing, productivity and healthcare experiences of Americans with employer-sponsored insurance.
Healthcare Ready, a nonprofit organization committed to protecting the U.S. healthcare system against disasters and pandemics, recently concluded an initiative aimed to understand the consequences of the COVID-19 pandemic and other disaster-related threats on the healthcare workforce.
As women age, hormonal shifts during menopause often bring visible changes in their physical appearance. Cynthia Elliott, M.D., owner and primary practitioner at Skinspirations, shed light on the concept of "menopause makeovers" and how medical aesthetic procedures can address these changes toward women.
It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
In the third part of this video series, Susan Cantrell, CEO of AMCP, discusses the impact of drug prices on patient adherence with Managed Healthcare Executive.
ONC201 (dordaviprone) displayed “well tolerated and durable and clinically meaningful efficacy in Histone 3 (H3) K27M mutant-diffuse midline glioma DMG.”
In this second part of a video series, AMCP CEO Susan Cantrell addressed the impact of high prescription drug prices on underserved communities, highlighting disparities in access caused by the pandemic's effects on minority populations. On the industry blame debate, she urged collaborative solutions, mentioning AMCP's engagement with diverse stakeholders to find comprehensive, patient-centric solutions and advocate for policy changes like the MVP Act to address rising costs and access challenges.
In this first part of a video series, Susan Cantrell, CEO of AMCP, discussed root causes of high drug prices, its impact on underserved communities and Medicare price negotiation, emphasizing AMCP's actions and the role of decreasing drug prices for equity.
Results of the evaluations will inform recommendations to payers and providers about whether and how to adopt these technologies.
This is ARPA-H’s first major deliverable of the White House Initiative on Women’s Health Research since the Agency was created in 2022 as part of President Biden’s bipartisan Unity Agenda, seeking to advance and accelerate health solutions.
In this month’s episode of Tuning In to the C-Suite, Briana Contreras, an editor of Managed Healthcare Executive, got to chatting with Sanjula Jain, Ph.D., chief research officer at Trilliant Health.
A coalition of women, including members of the Democratic Women’s Caucus (DWC), Pro-Choice Caucus Contraception & Family Planning Task Force, and Senators, took the lead in rallying over 150 House and Senate Democratic colleagues, after the large group of lawmakers wrote a letter yesterday to America’s Health Insurance Plans (AHIP) President and CEO Mike Tuffin addressing that AHIP’s “members are not complying with the Affordable Care Act contraception coverage requirement.."
This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
Stephen Greene, MD, of Duke University School of Medicine, explains that Inpefa (sotagliflozin), a recently FDA-approved dual SGLT-1 and SGLT-2 inhibitor, aims to reduce cardiovascular death, heart failure, hospitalizations, or urgent heart failure visits among patients with heart failure, chronic kidney disease, type 2 diabetes, and another cardiovascular risk factor.
Published by Coherent Market Insights, the report shared the healthcare staffing market was valued at $36.89 billion in 2022.
The biopharmaceutical company developed VTAMA cream as a once-daily and steroid-free topical cream for both acute treatment and long-term management of AD.
Up to 50% of women have reported that they struggle with sleep issues in midlife, while CVD stands as the main cause of death in women.
Providing support to those transitioning into life after incarceration is crucial. This group often faces complex health risks after their release, and maintaining consistent access to substance use disorder treatment plays a significant role in reducing the risk of reincarceration, relapse, and overdose.
Swimming in cold water can help ease menstrual and perimenopausal symptoms like anxiety and mood swings, according to a recent study published in Sage Journals.
Through investments made by the Bipartisan Safer Communities Act (BSCA), the grants will be awarded to 20 states of up to $2.5 million to support the implementation, improvement and expansion of school-based health services through Medicaid and the Children’s Health Insurance Program (CHIP).
The healthcare company will add new members to their teams while others expand their roles, and some retire from them.
Those who suffer from obesity, heavy smoking and short sleep have a higher chance of developing mass spectrometry (MS) and monoclonal gammopathy of undetermined significance (MGUS), which can often lead to multiple myeloma.
The smartphone app is currently under investigation in the CONVOKE study as a pharmaceutical therapy, aiming to address the negative symptoms associated with adult schizophrenia.
